Yao Yu
Yao Yu
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Handbook of evidence-based radiation oncology
EK Hansen, M Roach
Springer, 2010
Temozolomide-associated hypermutation in gliomas
S Choi, Y Yu, MR Grimmer, M Wahl, SM Chang, JF Costello
Neuro-oncology 20 (10), 1300-1309, 2018
Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure
EA Wiegner, ME Daly, JD Murphy, J Abelson, CH Chapman, M Chung, ...
International Journal of Radiation Oncology* Biology* Physics 83 (1), 243-251, 2012
Long‐term experience with reduced planning target volume margins and intensity‐modulated radiotherapy with daily image‐guidance for head and neck cancer
AM Chen, Y Yu, ME Daly, DG Farwell, S H. Benedict, JA Purdy
Head & neck 36 (12), 1766-1772, 2014
JAVELIN head and neck 100: a phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer
Y Yu, NY Lee
Future Oncology 15 (7), 687-694, 2019
High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors
JC Hong, Y Yu, AK Rao, S Dieterich, PG Maxim, QT Le, M Diehn, DY Sze, ...
International Journal of Radiation Oncology* Biology* Physics 81 (1), 85-90, 2011
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas
Y Yu, J Villanueva-Meyer, MR Grimmer, S Hilz, DA Solomon, S Choi, ...
Neuro-oncology 23 (11), 1872-1884, 2021
Target volume delineation and field setup: a practical guide for conformal and intensity-modulated radiation therapy
NY Lee, JJ Lu, Y Yu
Springer, 2013
Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma
RR Joshi, Q Husain, BR Roman, J Cracchiolo, Y Yu, J Tsai, J Kang, ...
Journal of surgical oncology 119 (1), 130-142, 2019
Comparison of daily versus nondaily image‐guided radiotherapy protocols for patients treated with intensity‐modulated radiotherapy for head and neck cancer
Y Yu, AL Michaud, R Sreeraman, T Liu, JA Purdy, AM Chen
Head & neck 36 (7), 992-997, 2014
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas
J Hayes, Y Yu, LE Jalbert, T Mazor, LE Jones, MD Wood, KM Walsh, ...
Neuro-oncology 20 (5), 632-641, 2018
Radiotherapy for hepatocellular carcinoma
Y Yu, M Feng
Seminars in Radiation Oncology 28 (4), 277-287, 2018
Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus–associated oropharyngeal carcinoma treated with definitive …
CJ Tsai, SM McBride, N Riaz, JJ Kang, DJ Spielsinger, T Waldenberg, ...
JAMA oncology 8 (3), 364-372, 2022
Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
JC Hong, NCW Eclov, Y Yu, AK Rao, S Dieterich, QT Le, M Diehn, DY Sze, ...
Journal of applied clinical medical physics 14 (2), 77-89, 2013
Toxicity profiles and survival outcomes among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated …
X Li, S Kitpanit, A Lee, D Mah, K Sine, EJ Sherman, LA Dunn, LS Michel, ...
JAMA Network Open 4 (6), e2113205-e2113205, 2021
The 3 Bs of cancer care amid the COVID‐19 pandemic crisis:“Be safe, be smart, be kind”—a multidisciplinary approach increasing the use of radiation and embracing telemedicine …
JJ Kang, RJ Wong, EJ Sherman, A Rybkin, SM McBride, N Riaz, CJ Tsai, ...
Cancer 126 (18), 4092-4104, 2020
Brain metastasis growth on preradiosurgical magnetic resonance imaging
MA Garcia, M Anwar, Y Yu, S Duriseti, B Merritt, J Nakamura, C Hess, ...
Practical radiation oncology 8 (6), e369-e376, 2018
Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer
TH Beckham, C Barney, E Healy, AR Wolfe, A Branstetter, A Yaney, ...
International journal of cancer 147 (1), 107-115, 2020
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma
E Katsoulakis, Y Yu, AP Apte, JE Leeman, N Katabi, L Morris, JO Deasy, ...
Oral oncology 110, 104877, 2020
Temporal lobe necrosis in head and neck cancer patients after proton therapy to the skull base
S Kitpanit, A Lee, KL Pitter, D Fan, JCH Chow, B Neal, Z Han, P Fox, ...
International journal of particle therapy 6 (4), 17-28, 2020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20